Skip to main content
Erschienen in: World Journal of Surgery 7/2008

01.07.2008

Intraoperative Application of Fibrin Sealant does not Reduce the Duration of Closed Suction Drainage Following Radical Axillary Lymph Node Dissection in Melanoma Patients: A Prospective Randomized Trial in 58 Patients

verfasst von: Heiko Neuss, Wieland Raue, Gerold Koplin, Wolfgang Schwenk, Christian Reetz, Julian W. Mall

Erschienen in: World Journal of Surgery | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients suffering from malignant melanoma often require radical lymph node dissection of the axillary nodal basin. The effects of intraoperative application of fibrin sealant following radical axillary lymph node dissection (RALND) on the incidence of postoperative lymphatic secretion are discussed. To study the effect of intraoperatively applied fibrin sealant following RALND a randomized patient-blinded trial was carried out.

Methods

Fifty-eight patients with axillary lymph node metastases of malignant melanoma underwent therapeutic RALND and were randomized into two groups: 29 patients received 2 cc of fibrin glue intraoperatively and 29 patients were only irrigated with 0.9% saline. The amount of drainage was recorded every 24 h. The main outcome criterion was the duration of drain placement in the wound. Minor criteria were the total amount of fluid and the length of hospital stay. Statistical analysis was performed using Spearman’s log–rank correlation and paired t-test.

Results

There was no significant difference between the nonfibrin group 5 days (range = 3.6–5.7 days) and the fibrin group 5 days (range = 4.1–8.5 days) (p = 0.701). The total amount of fluid for the nonfibrin group (410 cc, range = 362–727 cc) and that for the fibrin group (503 cc, range = 369–1098 cc) (p = 0.605) and the length of postoperative hospital stay of 6 days (range = 5.4–7) vs. 7 days (range = 5.9–10.7), respectively, were not different between both groups (p = 0.387).

Conclusion

Considering our study results, we cannot recommend the use of 2 cc of fibrin glue intraoperatively in the prevention of lymphatic secretion in patients undergoing RALND for metastatic melanoma.
Literatur
1.
Zurück zum Zitat de Vries M, Vonkeman WG, van Ginkel RJ et al (2005) Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol 31(7):778–783PubMedCrossRef de Vries M, Vonkeman WG, van Ginkel RJ et al (2005) Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol 31(7):778–783PubMedCrossRef
2.
Zurück zum Zitat Allen PJ, Coit DG (2002) The surgical management of metastatic melanoma. Ann Surg Oncol 9(8):762–770PubMedCrossRef Allen PJ, Coit DG (2002) The surgical management of metastatic melanoma. Ann Surg Oncol 9(8):762–770PubMedCrossRef
3.
Zurück zum Zitat Allen PJ, Coit DG (2002) The role of surgery for patients with metastatic melanoma. Curr Opin Oncol 14(2):221–226PubMedCrossRef Allen PJ, Coit DG (2002) The role of surgery for patients with metastatic melanoma. Curr Opin Oncol 14(2):221–226PubMedCrossRef
4.
Zurück zum Zitat Balch CM (1990) Axillary lymph node dissection: differences in goals and techniques when treating melanoma and breast cancer. Surgery 108(1):118–119PubMed Balch CM (1990) Axillary lymph node dissection: differences in goals and techniques when treating melanoma and breast cancer. Surgery 108(1):118–119PubMed
5.
Zurück zum Zitat Bevilacqua RG, Coit DG, Rogatko A et al (1990) Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg 212(2):125–131PubMedCrossRef Bevilacqua RG, Coit DG, Rogatko A et al (1990) Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg 212(2):125–131PubMedCrossRef
6.
Zurück zum Zitat Karakousis CP, Hena MA, Emrich LJ et al (1990) Axillary node dissection in malignant melanoma: results and complications. Surgery 108(1):10–17PubMed Karakousis CP, Hena MA, Emrich LJ et al (1990) Axillary node dissection in malignant melanoma: results and complications. Surgery 108(1):10–17PubMed
7.
Zurück zum Zitat Karakousis CP, Goumas W, Rao U et al (1991) Axillary node dissection in malignant melanoma. Am J Surg 162(3):202–207PubMedCrossRef Karakousis CP, Goumas W, Rao U et al (1991) Axillary node dissection in malignant melanoma. Am J Surg 162(3):202–207PubMedCrossRef
8.
Zurück zum Zitat Kretschmer L, Preusser KP (2001) Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma. Langenbecks Arch Surg 386(6):418–425PubMedCrossRef Kretschmer L, Preusser KP (2001) Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma. Langenbecks Arch Surg 386(6):418–425PubMedCrossRef
9.
Zurück zum Zitat Waclawiczek HW, Pimpl W (1986) Lymph fistulae following lymph node dissections–prevention and treatment using fibrin gluing. Chirurg 57(5):330–331PubMed Waclawiczek HW, Pimpl W (1986) Lymph fistulae following lymph node dissections–prevention and treatment using fibrin gluing. Chirurg 57(5):330–331PubMed
10.
Zurück zum Zitat Mustonen PK, Harma MA, Eskelinen MJ (2004) The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg 93(3):209–212PubMed Mustonen PK, Harma MA, Eskelinen MJ (2004) The effect of fibrin sealant combined with fibrinolysis inhibitor on reducing the amount of lymphatic leakage after axillary evacuation in breast cancer. A prospective randomized clinical trial. Scand J Surg 93(3):209–212PubMed
11.
Zurück zum Zitat Jain PK, Sowdi R, Anderson AD et al (2004) Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg 91(1):54–60PubMedCrossRef Jain PK, Sowdi R, Anderson AD et al (2004) Randomized clinical trial investigating the use of drains and fibrin sealant following surgery for breast cancer. Br J Surg 91(1):54–60PubMedCrossRef
12.
Zurück zum Zitat Balch CM, Buzaid AC, Soong SJ et al (2003) New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21(1):43–52PubMedCrossRef Balch CM, Buzaid AC, Soong SJ et al (2003) New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 21(1):43–52PubMedCrossRef
13.
Zurück zum Zitat Moore MM, Nguyen DH, Spotnitz WD (1997) Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg 63(1):97–102PubMed Moore MM, Nguyen DH, Spotnitz WD (1997) Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial. Am Surg 63(1):97–102PubMed
14.
Zurück zum Zitat Tejler G, Aspegren K (1985) Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg 72(7):542–544PubMedCrossRef Tejler G, Aspegren K (1985) Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg 72(7):542–544PubMedCrossRef
15.
Zurück zum Zitat Vinton AL, Traverso LW, Jolly PC (1991) Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 161(5):584–588PubMedCrossRef Vinton AL, Traverso LW, Jolly PC (1991) Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 161(5):584–588PubMedCrossRef
16.
Zurück zum Zitat Vaxman F, Kolbe A, Stricher F et al (1995) Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 27(5):346–352PubMedCrossRef Vaxman F, Kolbe A, Stricher F et al (1995) Does fibrin glue improve drainage after axillary lymph node dissection? Prospective and randomized study in humans. Eur Surg Res 27(5):346–352PubMedCrossRef
17.
Zurück zum Zitat Dinsmore RC, Harris JA, Gustafson RJ (2000) Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. Am Surg 66(10):982–985PubMed Dinsmore RC, Harris JA, Gustafson RJ (2000) Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial. Am Surg 66(10):982–985PubMed
18.
Zurück zum Zitat Gilly FN, Francois Y, Sayag-Beaujard AC et al (1998) Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res 30(6):439–443PubMedCrossRef Gilly FN, Francois Y, Sayag-Beaujard AC et al (1998) Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: prospective randomized trial. Eur Surg Res 30(6):439–443PubMedCrossRef
19.
Zurück zum Zitat Moore M, Burak WE Jr, Nelson E et al (2001) Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 192(5):591–599PubMedCrossRef Moore M, Burak WE Jr, Nelson E et al (2001) Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 192(5):591–599PubMedCrossRef
20.
Zurück zum Zitat Furrer M, Inderbitzi R, Nachbur B (1993) Does administration of fibrin glue prevent development of lymphoceles after radical lymphadenectomy? Chirurg 64(12):1044–1049PubMed Furrer M, Inderbitzi R, Nachbur B (1993) Does administration of fibrin glue prevent development of lymphoceles after radical lymphadenectomy? Chirurg 64(12):1044–1049PubMed
Metadaten
Titel
Intraoperative Application of Fibrin Sealant does not Reduce the Duration of Closed Suction Drainage Following Radical Axillary Lymph Node Dissection in Melanoma Patients: A Prospective Randomized Trial in 58 Patients
verfasst von
Heiko Neuss
Wieland Raue
Gerold Koplin
Wolfgang Schwenk
Christian Reetz
Julian W. Mall
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9461-0

Weitere Artikel der Ausgabe 7/2008

World Journal of Surgery 7/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.